Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
13 Results Found
AHA, Others File Brief in Missouri to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements
The American Hospital Association, 340B Health, and the American Society of Health-System Pharmacists (collectively, the “Proposed Amici”) respectfully move this Court for leave to file the attached amicus curiae brief in support of Defendants Attorney General Andrew Bailey, President of the Missouri Board of Pharmacy James L. Gray, Vice President of the Missouri Board of Pharmacy Christian S. Tadrus, and Members of the Missouri Board of Pharmacy Douglas R. Lang, Colby Grove, Anita K. Parran, Tammy Thompson, and Darren Harris’s Motion to Dismiss and Opposition to Plaintiff Novartis Pharmaceuticals Corporation’s Motion for Preliminary Injunction (Exhibit A).
Urge Your Representative to Sign Letter for HHS to Act on J&J 340B Proposal
Reps. Abigail Spanberger (D-Va.), Dusty Johnson (R-S.D.), Doris Matsui (D-Calif.), Debbie Dingell (D-Mich.), Tracey Mann (R-Kan.) and Rob Wittman (R-Va.) are asking representatives to sign onto a letter to the Department of Health and Human Services urging it to take action to stop Johnson & Johnson’s (J&J) plan “to upend more than 30 years of federal law by delaying access to 340B Drug Pricing Program (340B) discounts on pharmaceuticals for certain safety-net hospitals.”
Senators seek stakeholder feedback on draft 340B legislation
A bipartisan group of senators Feb. 2 released for stakeholder feedback a discussion draft of legislation to clarify in statute Congress’ intent for the 340B program to help safety net providers maintain, improve and expand patient access to health care services by requiring drug manufacturers that participate in Medicaid and Medicare Part B to provide discounts and rebates to covered entities that serve a disproportionate share of low-income and underserved patients.
AHA Comments on 340B Drug Pricing Program, IRF Payments, Physician Fee Schedule and Telehealth
AHA comments on MedPAC topics to be considered in the new cycle: the 340B Drug Pricing Program, inpatient rehabilitation facility (IRF) payments, the physician fee schedule (PFS) and telehealth.
Joint Statement From National Hospital Associations on PhRMA-Led Proposal to Restrict 340B Eligibility
Hospital and pharmacist advocates for safety-net health care and affordable prescription drugs are united in their firm opposition to a misguided effort by the drug industry and some community health centers that would restrict access to the 340B drug pricing program.
AHA 340B Advocacy Alliance Bulletin - March 20, 2023
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only save drug company profits by reducing their already modest financial contribution to the health care safety net,” the AHA and other national hospital groups said in a statement today.
Golden Valley Memorial Healthcare | Missouri
Golden Valley Memorial Healthcare (GVMH) has served the people of Missouri for over 50 years. Based in Clinton, Missouri, GVMH is the only hospital serving three rural counties between Kansas City and Springfield, covering an 80-mile radius.
AHA, 340B Health, Arkansas Hospital Association Urge Federal Appeals Court 340B Community Pharmacies to Uphold State Law Protecting
The American Hospital Association (AHA), 340B Health, and the Arkansas Hospital Association told the U.S. Court of Appeals for the Eighth Circuit that Arkansas’s 340B Drug Pricing Nondiscrimination Act does not conflict with federal law but rather supports Congress’s goal in enacting the 340B program.
Advancing Health in America Is a Bipartisan Goal We Can All Get Behind
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment.
AHA 340B Advocacy Alliance Bulletin - July 22, 2022
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.7% in calendar year 2023 compared to 2022.